Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

  1. Obach, V.
  2. Velasco, F.
  3. Alvarez Escudero, R.
  4. Martín Bujanda, M.
  5. Aranceta, S.
  6. Fabregat, N.
  7. Marco, T.
  8. Ruisanchez, A.
  9. Roncero, N.
  10. Mínguez-Olaondo, A.
  11. Ruibal, M.
  12. Guisado-Alonso, D.
  13. Moreira, A.
  14. Cuadrado-Godia, E.
  15. Echeverria, A.
  16. Kortazar Zubizarreta, I.
  17. López-Bravo, A.
  18. Riesco, N.
  19. González-Fernández, L.
  20. Pola, N.
  21. Manera, P.
  22. Guerrero-Peral, Á.L.
  23. Oterino Duran, A.
  24. González-Osorio, Y.
  25. Armand, R.
  26. Fernández-Fernández, S.
  27. García-Azorín, D.
  28. García-Moncó, J.C.
  29. Erakutsi egile guztiak +
Aldizkaria:
Journal of Headache and Pain

ISSN: 1129-2377 1129-2369

Argitalpen urtea: 2023

Alea: 24

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/S10194-023-01690-2 GOOGLE SCHOLAR lock_openSarbide irekia editor